Student
Adelaide University, Australia
Baljinder Singh is a pharmaceutical scientist specializing in long-acting drug delivery systems. He focuses on the design and development of in situ forming implants and organogels for sustained combination therapy in neurodegenerative disorders, including Alzheimer’s disease. His work integrates formulation optimization, in vitro and ex vivo evaluation, and advanced analytical techniques to improve drug release and patient compliance.